Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Isabella Fokt"'
Autor:
Jun Wei, Adam Wu, Ling-Yuan Kong, Yongtao Wang, Gregory Fuller, Isabella Fokt, Giovanni Melillo, Waldemar Priebe, Amy B Heimberger
Publikováno v:
PLoS ONE, Vol 6, Iss 1, p e16195 (2011)
Glioblastoma multiforme (GBM) is a lethal cancer that exerts potent immune suppression. Hypoxia is a predominant feature of GBM, but it is unclear to the degree in which tumor hypoxia contributes to this tumor-mediated immunosuppression. Utilizing GB
Externí odkaz:
https://doaj.org/article/bb59fb0ce67a4fce9481daec3bc2709c
Autor:
Amy B. Heimberger, Waldemar Priebe, Isabella Fokt, Timothy Madden, Charles Conrad, Justin Jordan, Ling-Yuan Kong, S. Farzana Hussain
Overcoming the profound immunosuppression in patients with solid cancers has impeded efficacious immunotherapy. Signal transducers and activators of transcription 3 (STAT3) has recently emerged as a potential target for effective immunotherapy, and i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed446783a30e3b79f77644555f095eff
https://doi.org/10.1158/0008-5472.c.6496889
https://doi.org/10.1158/0008-5472.c.6496889
Autor:
Amy B. Heimberger, Waldemar Priebe, Isabella Fokt, Timothy Madden, Charles Conrad, Justin Jordan, Ling-Yuan Kong, S. Farzana Hussain
Supplementary Figure 1 from A Novel Small Molecule Inhibitor of Signal Transducers and Activators of Transcription 3 Reverses Immune Tolerance in Malignant Glioma Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::886c90e6981816d5a20a28885a9a72e1
https://doi.org/10.1158/0008-5472.22371689.v1
https://doi.org/10.1158/0008-5472.22371689.v1
Autor:
Justin T. Jordan, Timothy Madden, Isabella Fokt, S. Farzana Hussain, Amy B. Heimberger, Charles A. Conrad, Ling Yuan Kong, Waldemar Priebe
Publikováno v:
Cancer research. 67(20)
Overcoming the profound immunosuppression in patients with solid cancers has impeded efficacious immunotherapy. Signal transducers and activators of transcription 3 (STAT3) has recently emerged as a potential target for effective immunotherapy, and i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce03e5ce79a8136e9f09f295ae1ccce4
https://pubmed.ncbi.nlm.nih.gov/17942891
https://pubmed.ncbi.nlm.nih.gov/17942891